[
  {
    "age": 45,
    "bmi": 23.5,
    "diagnosis": "CD",
    "sample_id": "IBD001",
    "treatment": "Infliximab",
    "visit_date": "2024-01-15"
  },
  {
    "age": 52,
    "bmi": 27.1,
    "diagnosis": "CD",
    "sample_id": "IBD002",
    "treatment": "adalimumab",
    "visit_date": "2024/02/20"
  },
  {
    "age": 38,
    "bmi": 21.8,
    "diagnosis": "CD",
    "sample_id": "IBD003",
    "treatment": "Infliximab",
    "visit_date": "15-Mar-2024"
  },
  {
    "age": 41,
    "bmi": 24.2,
    "diagnosis": "UC",
    "sample_id": "IBD004",
    "treatment": "Vedolizumab",
    "visit_date": "2024-04-10"
  },
  {
    "age": 29,
    "bmi": -5.2,
    "diagnosis": "UC",
    "sample_id": "IBD005",
    "treatment": "mesalamine",
    "visit_date": "April 5, 2024"
  },
  {
    "age": 55,
    "bmi": 26.8,
    "diagnosis": "CD",
    "sample_id": "IBD006",
    "treatment": "Ustekinumab",
    "visit_date": "2024-05-22"
  },
  {
    "age": 44,
    "bmi": 22.9,
    "diagnosis": "CD",
    "sample_id": "IBD007",
    "treatment": "Infliximab",
    "visit_date": "2024-06-18"
  },
  {
    "age": 33,
    "bmi": 28.5,
    "diagnosis": "UC",
    "sample_id": "IBD008",
    "treatment": "Vedolizumab",
    "visit_date": "2024-07-03"
  }
]